Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
出版年份 2014 全文链接
标题
Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
作者
关键词
-
出版物
ANNALS OF THE RHEUMATIC DISEASES
Volume 75, Issue 1, Pages 303-310
出版商
BMJ
发表日期
2014-11-11
DOI
10.1136/annrheumdis-2014-205326
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Plasminogen Activator System in Fibroblasts from Systemic Sclerosis
- (2017) L. Postiglione et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
- (2013) Mirko Manetti et al. ANNALS OF THE RHEUMATIC DISEASES
- miR-193b Regulates Mcl-1 in Melanoma
- (2011) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance
- (2011) F. Niederer et al. ANNALS OF THE RHEUMATIC DISEASES
- MicroRNAs in the cardiovascular system
- (2011) Mingyue Han et al. CURRENT OPINION IN CARDIOLOGY
- MicroRNA therapeutics
- (2011) J A Broderick et al. GENE THERAPY
- Identification of miR-193b Targets in Breast Cancer Cells and Systems Biological Analysis of Their Functional Impact
- (2011) Suvi-Katri Leivonen et al. MOLECULAR & CELLULAR PROTEOMICS
- The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers
- (2011) James S. Wilmott et al. PATHOLOGY
- MicroRNAs in the Pathogenesis of Cancer
- (2011) Francesca Lovat et al. SEMINARS IN ONCOLOGY
- MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
- (2010) Britta Maurer et al. ARTHRITIS AND RHEUMATISM
- Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation
- (2010) Joanna Stanczyk et al. ARTHRITIS AND RHEUMATISM
- miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer
- (2010) Hanna E. Rauhala et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of a novel microRNA clustermiR-193b-365in multiple myeloma
- (2010) Kenji Unno et al. LEUKEMIA & LYMPHOMA
- MicroRNA array analysis of microRNAs related to systemic scleroderma
- (2010) Haitao Li et al. RHEUMATOLOGY INTERNATIONAL
- Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activatorThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Special Issue).
- (2009) Vsevolod A. Tkachuk et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer
- (2009) X-F Li et al. ONCOGENE
- Evolution of microRNAs and their targets: Are all microRNAs biologically relevant?
- (2008) M AXTELL Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
- (2008) Ausra Milano et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started